March 18, 2019
The Japanese Cabinet approved on March 15 a draft governmental ordinance to raise the Pharmaceuticals and Medical Devices Agency’s (PMDA) review fees for drugs, medical devices, and regenerative medicine products, as well as GMP inspection fees. The new ordinance, which...read more